Activity of Temozolomide and Bevacizumab in the Treatment of Locally Advanced, Recurrent, and Metastatic Hemangiopericytoma and Malignant Solitary Fibrous Tumor

BACKGROUND: Hemangiopericytomas and malignant solitary fibrous tumors (HPC/SFT) are rare, closely related sarcomas with unpredictable behavior that respond infrequently to chemotherapy. An optimal systemic treatment strategy for advanced HPC/SFT has not yet been identified. METHODS: We retrospective...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Park, Min S., Patel, Shreyaskumar R., Ludwig, Joseph A., Trent, Jonathan C., Conrad, Charles A., Lazar, Alexander J., Wang, Wei-Lien, Boonsirikamchai, Piyaporn, Choi, Haesun, Wang, Xuemei, Benjamin, Robert S., Araujo, Dejka M.
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3135685/
https://ncbi.nlm.nih.gov/pubmed/21480200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26098
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares